Dr. Bingyin Wang joins LinkZill as Director of Life Sciences BU!

2025-12-25

We are excited to announce that Dr. Bingyin (Brian) Wang joined LinkZill as Director of Life Sciences BU. With strong commercialization capabilities and proven cross-border expertise, he is set to drive our expansion into the field of life sciences.

Brian holds a bachelor’s and master’s degree from Fudan University, complemented by a PhD in Molecular Biology from Stony Brook University in New York. Brian has forged an extraordinary career anchored in top-tier academic rigor and cross-border practical expertise. His nearly decade-long tenure at IDT —Danaher’s globally leading enterprise in DNA chemistry synthesis, served as a pivotal chapter in his professional journey. Starting as a frontline Application Scientist, he honed his skills across diverse roles including Product Management, Sales, Marketing, Application Support and External Innovation. After relocating to China full-time in 2019, he emerged as a core pioneer of the brand’s domestic business, contributing to its rooted growth in the Chinese market. Through these experiences he amassed profound hands-on expertise in the technology commercialization in both China and US, also dedicating himself wholeheartedly to the DNA synthesis landscape and shaping the industry’s trajectory with professionalism and foresight.

In early 2024, Brian joined a listed company in China’s life sciences sector as a key executive. He integrated advanced management philosophies represented by DBS into marketing operations, technical empowerment, supply chain management and oversea market expansion, staying true to his mission of empowering the organization. At the end of Nov 2025, he returned to his familiar DNA synthesis domain, joining LinkZill Technology to lead the Life Sciences Business Unit.

With his profound industry insights and comprehensive commercialization capabilities, he is poised to write a new chapter of deep expertise and innovative excellence in his career.

We are excited to move forward with Brian as we advance our vision of transforming the life sciences through TFT semiconductor technology. Welcome aboard, Brian!

Dr. Kang Kang

Partner & CBio

Dr. Kang received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong in 2018, then became a scientific co-worker of the Leibniz Association (Leibniz-HKI) and a visiting scientist at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark. He was a scientist at BGI-Shenzhen and co-founded the synthetic biology research group. He was a senior bioinformatics engineer and brand advisor at WeGene. In 2021, Kang joined Biosysen Limited as a co-founder and served as Chief Informatics Scientist. He is also an advisor and author of the biotech media "Regenesis". He has been dedicated to the R&D and industrialization of OMICs technologies, high-throughput technologies, and synthetic biology for over 10 years. He joined LinkZill in March 2023, responsible for semiconductor life science tools and product planning.

康康   博士

合伙人兼首席生物信息官

博士毕业于香港大学生物信息和系统生物学专业,后任德国莱布尼茨协会科学合作者、丹麦科技大学诺和诺德生物可持续研究中心访问科学家。曾先后担任华大基因科学家,参与创立了华大基因合成生物学研究方向;微基因资深生物信息工程师、品牌顾问;倍生生物联合创始人兼首席信息科学家。他专注于合成生物学、组学和高通量技术10余年,同时也是生物技术领域颇具影响力的「行业KOL」。2023年3月加入领挚科技,负责半导体生命科学工具方向与产品规划。